Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Alfimeprase: Phase II halted

NUVO closed enrollment early in its U.S. double-blind Phase II trial of alfimeprase to treat venous catheter occlusion.

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE